Exchange: NASDAQ·Updated 04:00 AM EDT
TLPH logo

TLPH Talphera Inc.

$1.19
$0.01
(0.85%)
Pre-Market
Prev Close $1.18
Reported EarningsAug 12
Mkt Cap$61.77M
Vol23.00

About TLPH

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes Nafamostat, LTX-608, and Niyad. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.
37

Bearish Sentiment

How do you feel about TLPH?

Advertisement|Remove ads.